Cargando…
Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC
Dysregulation of histone modifications has been implicated in the pathogenesis of both inflammatory bowel disease (IBD) and colorectal cancer (CRC). These diseases are characterized by chronic inflammation, and alterations in histone modifications have been linked to their development and progressio...
Autores principales: | Liang, Bing, Wang, Yanhong, Xu, Jiazhen, Shao, Yingchun, Xing, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496233/ https://www.ncbi.nlm.nih.gov/pubmed/37697409 http://dx.doi.org/10.1186/s13148-023-01562-1 |
Ejemplares similares
-
Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection
por: Chen, Wujun, et al.
Publicado: (2022) -
Host histone acetylation unlocks HDAC inhibitor potential
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017) -
Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro
por: Xia, Xuan, et al.
Publicado: (2023) -
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2022) -
Unlocking the Secret to Higher Crop Yield: The Potential for Histone Modifications
por: Fang, Weiwei, et al.
Publicado: (2023)